Literature DB >> 16227286

Selection of muscle-binding peptides from context-specific peptide-presenting phage libraries for adenoviral vector targeting.

Debadyuti Ghosh1, Michael A Barry.   

Abstract

Production of cell-targeting vectors in part involves the addition of new targeting ligands to the vector to mediate binding to the cells of interest. For viral vectors, the ideal approach is to genetically engineer new ligands into the capsid proteins of the virus to generate a single agent to mediate therapy. Although this is ideal, this insertion of an exogenous ligand from one structural context into the differing structural context of a capsid protein can ablate the function of the ligand or disrupt viral assembly and function. To address this context problem for adenoviral vectors, we have engineered a "context-specific" peptide-presenting phage library. We have displayed a 12-amino-acid (12-mer) random peptide library between the H and I sheets of the fiber protein of adenovirus type 5 on the pIII protein of fd bacteriophage. This library was used for peptide selection against C2C12 mouse skeletal muscle cells. Five rounds of selection combined with four rounds of clearing on nontarget cells selected one primary peptide designated 12.51, which bound target C2C12 cells approximately 100-fold better than the positive control RGD peptide. Translation of 12.51 back into the fiber protein produced a ligand-modified adenoviral vector that mediated 14-fold-better transduction of target C2C12 cells. These data suggest context-specific peptide-presenting libraries may allow selection of compatible peptide ligands for functional translation into viral vectors for retargeting.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16227286      PMCID: PMC1262619          DOI: 10.1128/JVI.79.21.13667-13672.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Identification of peptides that target the endothelial cell-specific LOX-1 receptor.

Authors:  S J White; S A Nicklin; T Sawamura; A H Baker
Journal:  Hypertension       Date:  2001-02       Impact factor: 10.190

2.  A new helper phage and phagemid vector system improves viral display of antibody Fab fragments and avoids propagation of insert-less virions.

Authors:  Glenn Soltes; Heather Barker; Kristine Marmai; Elaine Pun; Amy Yuen; Erik J Wiersma
Journal:  J Immunol Methods       Date:  2003-03-01       Impact factor: 2.303

3.  The role of receptors in the maturation-dependent adenoviral transduction of myofibers.

Authors:  B Cao; R Pruchnic; M Ikezawa; X Xiao; J Li; T J Wickham; I Kovesdi; W A Rudert; J Huard
Journal:  Gene Ther       Date:  2001-04       Impact factor: 5.250

4.  Phage display of adenovirus type 5 fiber knob as a tool for specific ligand selection and validation.

Authors:  A Pereboev; L Pereboeva; D T Curiel
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

5.  Polylysine modification of adenoviral fiber protein enhances muscle cell transduction.

Authors:  K Bouri; W G Feero; M M Myerburg; T J Wickham; I Kovesdi; E P Hoffman; P R Clemens
Journal:  Hum Gene Ther       Date:  1999-07-01       Impact factor: 5.695

6.  Phage display selection of peptides that affect prostate carcinoma cells attachment and invasion.

Authors:  V I Romanov; D B Durand; V A Petrenko
Journal:  Prostate       Date:  2001-06-01       Impact factor: 4.104

7.  Modification of an adenoviral vector with biologically selected peptides: a novel strategy for gene delivery to cells of choice.

Authors:  H Romanczuk; C E Galer; J Zabner; G Barsomian; S C Wadsworth; C R O'Riordan
Journal:  Hum Gene Ther       Date:  1999-11-01       Impact factor: 5.695

8.  In vivo hepatic adenoviral gene delivery occurs independently of the coxsackievirus-adenovirus receptor.

Authors:  Theodore Smith; Neeraja Idamakanti; Helen Kylefjord; Michele Rollence; Laura King; Michele Kaloss; Michael Kaleko; Susan C Stevenson
Journal:  Mol Ther       Date:  2002-06       Impact factor: 11.454

9.  Muscle-specific overexpression of the adenovirus primary receptor CAR overcomes low efficiency of gene transfer to mature skeletal muscle.

Authors:  J Nalbantoglu; N Larochelle; E Wolf; G Karpati; H Lochmuller; P C Holland
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

10.  Selection of chronic lymphocytic leukemia binding peptides.

Authors:  Satoshi Takahashi; Hoyin Mok; M Brandon Parrott; Frank C Marini; Michael Andreeff; Malcolm K Brenner; Michael A Barry
Journal:  Cancer Res       Date:  2003-09-01       Impact factor: 12.701

View more
  14 in total

Review 1.  Improving Molecular Therapy in the Kidney.

Authors:  Jeffrey D Rubin; Michael A Barry
Journal:  Mol Diagn Ther       Date:  2020-08       Impact factor: 4.074

Review 2.  Current advances and future challenges in Adenoviral vector biology and targeting.

Authors:  Samuel K Campos; Michael A Barry
Journal:  Curr Gene Ther       Date:  2007-06       Impact factor: 4.391

Review 3.  Molecular engineering of viral gene delivery vehicles.

Authors:  David V Schaffer; James T Koerber; Kwang-il Lim
Journal:  Annu Rev Biomed Eng       Date:  2008       Impact factor: 9.590

4.  Adenovirus targeting to prostate-specific membrane antigen through virus-displayed, semirandom peptide library screening.

Authors:  Ping Wu; Tarana A Kudrolli; Wasim H Chowdhury; Minzhi M Liu; Ronald Rodriguez; Shawn E Lupold
Journal:  Cancer Res       Date:  2010-07-29       Impact factor: 12.701

5.  Refactored M13 bacteriophage as a platform for tumor cell imaging and drug delivery.

Authors:  Debadyuti Ghosh; Aditya G Kohli; Felix Moser; Drew Endy; Angela M Belcher
Journal:  ACS Synth Biol       Date:  2012-09-24       Impact factor: 5.110

Review 6.  Perspective on Adeno-Associated Virus Capsid Modification for Duchenne Muscular Dystrophy Gene Therapy.

Authors:  Michael E Nance; Dongsheng Duan
Journal:  Hum Gene Ther       Date:  2015-10-15       Impact factor: 5.695

Review 7.  Antisense-mediated exon skipping: a versatile tool with therapeutic and research applications.

Authors:  Annemieke Aartsma-Rus; Gert-Jan B van Ommen
Journal:  RNA       Date:  2007-08-07       Impact factor: 4.942

Review 8.  Retargeting adenoviruses for therapeutic applications and vaccines.

Authors:  Michael A Barry; Jeffrey D Rubin; Shao-Chia Lu
Journal:  FEBS Lett       Date:  2020-02-03       Impact factor: 4.124

9.  Retargeted and detargeted adenovirus for gene delivery to the muscle.

Authors:  Tien V Nguyen; Stephanie S Anguiano-Zarate; William E Matchett; Mary E Barry; Michael A Barry
Journal:  Virology       Date:  2017-11-22       Impact factor: 3.616

10.  Dual systemic tumor targeting with ligand-directed phage and Grp78 promoter induces tumor regression.

Authors:  Azadeh Kia; Justyna M Przystal; Nastasia Nianiaris; Nicholas D Mazarakis; Paul J Mintz; Amin Hajitou
Journal:  Mol Cancer Ther       Date:  2012-10-10       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.